<DOC>
	<DOCNO>NCT00626444</DOCNO>
	<brief_summary>Eligible candidate adult aggressive aggressive NHL ( WHO classification diagnosis confirm histological tumor examination ) . Patients must fail one prior NHL chemotherapy antibody therapy curative intent , disease must progress within 60 day last therapy . In addition , patient must candidate potentially curative therapy , HSCT , must refuse alternative therapy . Full inclusion/exclusion criterion available . History physical examination , laboratory imaging analyse do within 14 day prior registration . Intravenous ascorbic acid give dose base plasma vitamin C level reach level range 300 350 mg/dL . Vitamin C infusion give three time week schedule allow least 24 hour infusion , total ten week ( 30 infusion ) . If disease progression occur ten week assessment , discontinue protocol , base futility . Toxicity adverse event also result immediate discontinuation ( detail available full protocol ) . If lack disease progression disease improvement , proceed reassess 10 week interval , total three 10 week interval . Initial criterion base upon criterion International Workshop Standardize Criteria Non-Hodgkin 's Lymphoma ( Cheson et al. , Report international workshop standardize response criterion non-Hodgkin 's lymphoma , Journal Clinical Oncology , 1999 , Vol . 17 , No4 , 1244-1253 ) ; response study utilize PET accordance revise criterion ( Cheson et al . Revised response criterion malignant lymphoma . J Clin Oncol 2007 ; 25 ( 5 ) : 579-586 ) . We select 20 patient appropriate study size evaluate true response rate therapy , compare observed response .</brief_summary>
	<brief_title>Pilot Trial Intravenous Vitamin C Refractory Non-Hodgkin Lymphoma ( NHL )</brief_title>
	<detailed_description />
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Lymphoma , Non-Hodgkin</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Ascorbic Acid</mesh_term>
	<criteria>Age great 18 year old Aggressive aggressive NHL Failed one therapy Patients must progress within 60 day last therapy Not receive allogeneic stem cell transplant No reasonable standard therapeutic option available Glucose 6 phosphate dehydrogenase status normal ECOG performance status 02 Normal creatinine transaminase Women childbearing potential confirm negative pregnancy test Significant comorbid disorder Significant psychiatric symptom Smoking Excessive alcohol drug use Enrollment experimental therapy Active infection Patients experience ongoing response recent treatment Patients receive chemotherapy within 30 day biological therapy within 6 week</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>